List of Excipients in API RIVAROXABAN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing RIVAROXABAN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | CELLULOSE, MICROCRYSTALLINE | |
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | CROSCARMELLOSE SODIUM | |
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | FERRIC OXIDE RED | |
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | HYPROMELLOSE | |
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | LACTOSE MONOHYDRATE | |
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | MAGNESIUM STEARATE | |
| A-S Medication Solutions | XARELTO | rivaroxaban | 50090-3625 | POLYETHYLENE GLYCOL 3350 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing RIVAROXABAN
Detailed excipient profiles for RIVAROXABAN
Excipient focus: ANHYDROUS CITRIC ACID
RIVAROXABAN drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
RIVAROXABAN drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen pharmaceuticalsInc | rivaroxaban | 50228-513 |
| Apotex Corp | rivaroxaban | 60505-6256 |
| Exelan pharmaceuticalsInc | rivaroxaban | 76282-774 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
RIVAROXABAN drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
RIVAROXABAN drug variants containing CELLULOSE, MICROCRYSTALLINE
RIVAROXABAN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen pharmaceuticalsInc | rivaroxaban | 50228-513 |
| Aurobindo Pharma Limited | rivaroxaban | 59651-849 |
| Apotex Corp | rivaroxaban | 60505-6256 |
| Exelan pharmaceuticalsInc | rivaroxaban | 76282-774 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
RIVAROXABAN drug variants containing CROSCARMELLOSE SODIUM
RIVAROXABAN drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
RIVAROXABAN drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | rivaroxaban | 31722-496 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FERRIC OXIDE RED
RIVAROXABAN drug variants containing FERRIC OXIDE RED
RIVAROXABAN drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
RIVAROXABAN drug variants containing FERRIC OXIDE YELLOW
RIVAROXABAN drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
RIVAROXABAN drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | rivaroxaban | 51672-4228 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
RIVAROXABAN drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | rivaroxaban | 51672-4228 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
RIVAROXABAN drug variants containing HYPROMELLOSE
RIVAROXABAN drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
RIVAROXABAN drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | rivaroxaban | 59651-849 |
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
RIVAROXABAN drug variants containing HYPROMELLOSES
RIVAROXABAN drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
RIVAROXABAN drug variants containing LACTOSE MONOHYDRATE
RIVAROXABAN drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen pharmaceuticalsInc | rivaroxaban | 50228-513 |
| Apotex Corp | rivaroxaban | 60505-6256 |
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Exelan pharmaceuticalsInc | rivaroxaban | 76282-774 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
RIVAROXABAN drug variants containing MAGNESIUM STEARATE
RIVAROXABAN drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
RIVAROXABAN drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
RIVAROXABAN drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | rivaroxaban | 59651-849 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
RIVAROXABAN drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | rivaroxaban | 59651-849 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLOXAMER 407
RIVAROXABAN drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | rivaroxaban | 60505-6256 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing POLOXAMER 407
Excipient focus: POLYETHYLENE GLYCOL
RIVAROXABAN drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | rivaroxaban | 31722-496 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
RIVAROXABAN drug variants containing POLYETHYLENE GLYCOL 3350
RIVAROXABAN drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
RIVAROXABAN drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | rivaroxaban | 33342-488 |
| ScieGen pharmaceuticalsInc | rivaroxaban | 50228-513 |
| Lupin Pharmaceuticals Inc | rivaroxaban | 68180-709 |
| Exelan pharmaceuticalsInc | rivaroxaban | 76282-774 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
RIVAROXABAN drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | rivaroxaban | 46708-346 |
| Alembic Pharmaceuticals Inc | rivaroxaban | 62332-346 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
RIVAROXABAN drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | rivaroxaban | 60505-6256 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
RIVAROXABAN drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen pharmaceuticalsInc | rivaroxaban | 50228-513 |
| Aurobindo Pharma Limited | rivaroxaban | 59651-849 |
| Apotex Corp | rivaroxaban | 60505-6256 |
| Exelan pharmaceuticalsInc | rivaroxaban | 76282-774 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
RIVAROXABAN drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | rivaroxaban | 33342-488 |
| Alembic Pharmaceuticals Limited | rivaroxaban | 46708-346 |
| Apotex Corp | rivaroxaban | 60505-6256 |
| Alembic Pharmaceuticals Inc | rivaroxaban | 62332-346 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
RIVAROXABAN drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM LAURYL SULFATE
RIVAROXABAN drug variants containing SODIUM LAURYL SULFATE
RIVAROXABAN drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | rivaroxaban | 60505-6256 |
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
RIVAROXABAN drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing SUCRALOSE
Excipient focus: TALC
RIVAROXABAN drug variants containing TALC
RIVAROXABAN drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
RIVAROXABAN drug variants containing TITANIUM DIOXIDE
RIVAROXABAN drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Florida Pharmaceutical Products LLC | rivaroxaban | 71921-405 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
Excipient focus: VANILLA
RIVAROXABAN drug variants containing VANILLA
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing VANILLA
Excipient focus: WATER
RIVAROXABAN drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Florida Pharmaceutical Products LLC | rivaroxaban | 71921-405 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing WATER
Excipient focus: XANTHAN GUM
RIVAROXABAN drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | rivaroxaban | 67877-882 |
| Lupin Pharmaceuticals Inc | rivaroxaban granule | 70748-355 |
| >Company | >Ingredient | >NDC |
RIVAROXABAN drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links